Evaluación de la seguridad de los anticoagulantes orales de acción directa

Gassó Sánchez, Amalia; Real Campaña, José Manuel; Franco Sorolla, José Miguel; Povar Marco, Bienvenido Javier; Abad Sazatornil, Maria Reyes.
Med. clín (Ed. impr.) ; 152(12): 482-487, jun. 2019. mapas, tab
Artículo en Español | IBECS (España) | ID: ibc-183318

Documentos relacionados

  1. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
  2. The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis.
  3. Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants: An Observational Registry Analysis.
  4. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
  5. Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation.
  6. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.
  7. Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials.
  8. Oral Anticoagulation in Patients in the Emergency Department: High Rates of Off-Label Doses, No Difference in Bleeding Rates.
  9. Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population.
  10. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation.